Related Experiment Video
Updated: May 16, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a
Asfar S Azmi1, Ginny W Bao, Jiankun Gao
1Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
Abstract:
Transcription factors (TFs) play central role in normal cellular physiology and their aberrant expression is linked to different diseases. Hepatocyte Nuclear Factors (HNFs) are TFs that have been recognized to play multiple roles in liver physiology. Emerging research has highlighted their function in the sustenance of solid tumors, indicating that HNFs could serve as possible therapeutic targets in cancer. Although, there have been many attempts to develop HNF targeted drugs, the myriad downstream targets associated with these transcription factors, some of which are critical for normal cell homeostasis, led to the realization that HNFs are not easily druggable. Therefore, identifying and optimizing drugs that can selectively inactivate HNFs is a challenge to the pharmaceutical industry. To achieve this, a more in-depth understanding is required of the HNFs binding partners, the protein interaction networks it regulates and the resulting phenotype. This calls for network analysis of the pathways regulated by HNFs and how chemical perturbations can selectively activate or suppress their functions. Network biology is an emerging field of research that is finding applications in cancer drug discovery. Specifically, network pharmacology is cementing its position in cancer research and has various applications such as biomarker identification, in determining synergistic drug pairs and in drug repurposing. Developing a network understanding of HNFs, the target it hits and responses thereof can enhance our ability to design drugs against these TFs. This article reviews how network pharmacology can help in the identification of druggable avenues in TFs and also allow the selection of drugs and their synergistic pairs against HNFs for cancer therapy.
Insights
Hepatocyte Nuclear Factors (HNFs) are crucial transcription factors in liver function and cancer. Network pharmacology offers a promising approach to identify selective drugs and synergistic pairs targeting HNFs for cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Systems Biology
Background:
- Transcription factors (TFs) regulate cellular processes; aberrant TF expression is linked to diseases.
- Hepatocyte Nuclear Factors (HNFs) are TFs vital for liver physiology and implicated in solid tumor progression.
- Targeting HNFs for cancer therapy is challenging due to their essential roles in normal cell homeostasis and complex downstream effects.
Purpose of the Study:
- To review the application of network pharmacology in understanding Hepatocyte Nuclear Factors (HNFs) in cancer.
- To explore how network biology approaches can identify druggable targets and therapeutic strategies for HNFs.
- To highlight the potential of network pharmacology in discovering selective drugs and synergistic drug pairs against HNFs for cancer treatment.
Main Methods:
- Review of current literature on Hepatocyte Nuclear Factors (HNFs) and their role in cancer.
- Exploration of network biology and network pharmacology principles.
- Analysis of how network approaches can elucidate TF binding partners, protein interaction networks, and cellular phenotypes.
- Discussion of chemical perturbations for selective modulation of HNF function.
Main Results:
- HNFs are implicated in sustaining solid tumors, presenting them as potential therapeutic targets.
- The complexity of HNF downstream targets makes them difficult to drug selectively.
- Network pharmacology provides a framework for understanding HNF networks, identifying biomarkers, and optimizing drug combinations.
Conclusions:
- Network pharmacology is a powerful tool for dissecting complex TF networks in cancer.
- Understanding HNF-regulated networks can lead to the identification of novel druggable targets.
- Network-based strategies can facilitate the development of selective therapies and synergistic drug pairs for HNF-driven cancers.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Pharmacogenomics: Identification of New Drug Targets
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Cell Specific Gene Expression
